Page last updated: 2024-08-17

levodopa and Cortical Lewy Body Disease

levodopa has been researched along with Cortical Lewy Body Disease in 47 studies

Research

Studies (47)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	24 (51.06)	29.6817
2010's	18 (38.30)	24.3611
2020's	5 (10.64)	2.80

Authors

Authors	Studies
MacDonald, S; Shah, AS; Tousi, B	1
Djoukhadar, I; Jabbari, E; Kobylecki, C; Lally, I; Leahy, CB; Morris, HR; Robinson, AC; Roncaroli, F	1
Asghar, M; Fattahi, AJ; Henriksson, AE; Khosousi, S; Miglar, A; Odeh, A; Svenningsson, P	1
Ikeda, M; Konishi, O; Mori, E; Orimo, S; Yamada, T	1
Imbimbo, BP; Lozupone, M; Panza, F; Watling, M	1
Hershey, LA; Irwin, DJ	1
Hasegawa, K; Iiyama, S; Kosaka, K; Murata, M; Nakamura, M; Odawara, T; Tagawa, M	1
Coleman-Jackson, R; Hershey, LA	1
Konishi, O; Manabe, Y; Odawara, T	1
Archie, A; Persoons, P; Vandenbulcke, M	1
Fujishiro, H; Kasanuki, K; Nakamura, S	1
Barrou, Z; Boddaert, J; Dieudonné, B; Faucounau, V; Greffard, S; Habert, MO; Verny, M	1
Kaur, M; Kushwaha, S; Malhotra, HS; Panda, AK	1
Kanaya, Y; Kono, R; Kuriyama, M; Shiga, Y; Shimoe, Y; Takeshima, S	1
Brandabur, M; Goetz, CG; Goldman, JG; Sanfilippo, M; Stebbins, GT	1
Aarsland, D; Ballard, CG; Ehrt, U; Francis, PT; Larsen, JP; Perry, EK; Perry, RH; Piggott, MA; Sharp, SI; Ziabreva, I	1
Boecker, H; Ceballos-Baumann, AO; Drzezga, A; Förstl, H; Granert, O; Häussermann, P; Kurz, A; Perneczky, R	1
Burn, DJ; McKeith, IG; Minett, T; Molloy, S; O'Brien, JT	1
McKeith, I	1
Heinz, A; Majic, T; Mell, T; Rapp, MA	1
Baldacci, F; Berti, C; Bonuccelli, U; Ceravolo, R; Del Dotto, P; Dolciotti, C; Gambaccini, G; Logi, C; Lucetti, C; Rossi, G	1
Tison, F	1
Aarsland, D; Engedal, K; Larsson, V; Londos, E; Minthon, L; Wattmo, C	1
Ohki, M; Tayama, N	1
Gomperts, SN; Growdon, JH; Johnson, KA; Locascio, JJ; Marquie, M; Maye, J; Rentz, DM; Santarlasci, AL	1
Wurtman, RJ	1
Antonini, A; Bonanni, L; Onofrj, M; Perfetti, B; Petrucci, S; Stocchi, F; Taylor, JP; Thomas, A; Valente, EM; Varanese, S	1
Sulkava, R	1
Hoefnagels, WH; Horstink, MW; Scheepmaker, AJ; Strijks, FE	1
Rajput, A; Rajput, AH; Robinson, CA	1
Finley, R; Lee, KC; Miller, B	1
Bonelli, SB; Deibl, M; Lampl, C; Lukas, T; Ransmayr, G; Steffelbauer, M	1
Burn, DJ; Firbank, MJ; McKeith, IG; O'Brien, JT	1
Driguès, N; Sagi, Y; Youdim, MB	1
Burn, DJ; McKeith, IG; Molloy, S; O'Brien, JT	1
Le Rhun, E; Lebert, F	1
Burn, DJ; McKeith, IG; Molloy, SA; O'Brien, JT; Rowan, EN; Wesnes, K	1
Damier, P; Meyniel, C	1
Bancher, C; Dal-Bianco, P; Jellinger, K; Katzenschlager, R; Poewe, W; Ransmayr, G; Schmidt, R; Wenning, G	1
Hamamoto, M; Katayama, Y; Mori, O; Nagayama, H; Nishiyama, Y; Ueda, M; Yamazaki, M	1
Jellinger, K; Poewe, W; Ransmayr, G; Seppi, K; Wenning, GK	1
Masson, C	1
Ballard, C; Campbell, S; Stephens, S	1
Ahlskog, JE; Apaydin, H; Boeve, BF; Dickson, DW; Parisi, JE	1
Kato, K; Kawakatsu, S; Otani, K; Wada, T	1
Burke, MA; Fernandez, HH; Friedman, JH; Trieschmann, ME	1

Reviews

9 review(s) available for levodopa and Cortical Lewy Body Disease

Article	Year
Current Therapies and Drug Development Pipeline in Lewy Body Dementia: An Update. Drugs & aging, 2022, Volume: 39, Issue:7 Topics: Dementia; Drug Development; Humans; Levodopa; Lewy Body Disease; Parkinson Disease	2022
Pharmacological Management of Dementia with Lewy Bodies. Drugs & aging, 2019, Volume: 36, Issue:4 Topics: Age Factors; Aged; Anticonvulsants; Antiparkinson Agents; Cholinesterase Inhibitors; Clinical Trials, Phase II as Topic; Clonazepam; Humans; Levodopa; Lewy Body Disease; Melatonin; Randomized Controlled Trials as Topic; Zonisamide	2019
["Red flags": when to be alerted and how to explore?]. Revue neurologique, 2010, Volume: 166, Issue:10 Topics: Antiparkinson Agents; Basal Ganglia Diseases; Biomarkers; Diagnosis, Differential; Humans; Levodopa; Lewy Body Disease; Magnetic Resonance Imaging; Multiple System Atrophy; Parkinson Disease; Supranuclear Palsy, Progressive	2010
Differential diagnosis between early Parkinson's disease and dementia with Lewy bodies. Advances in neurology, 2003, Volume: 91 Topics: Brain; Cognition Disorders; Diagnosis, Differential; Disease Progression; Hallucinations; Humans; Levodopa; Lewy Body Disease; Mood Disorders; Parkinson Disease	2003
[Treatment of dementia with Lewy bodies]. Revue neurologique, 2006, Volume: 162, Issue:1 Topics: Antiparkinson Agents; Antipsychotic Agents; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Case Management; Cholinesterase Inhibitors; Combined Modality Therapy; Drug Resistance; Drug Therapy, Combination; Hallucinations; Humans; Levodopa; Lewy Body Disease; Mental Disorders; Mood Disorders; Nootropic Agents; Physical Therapy Modalities; Sleep Wake Disorders; Speech Therapy	2006
[Lewy body dementia and Parkinson disease dementia]. Presse medicale (Paris, France : 1983), 2007, Volume: 36, Issue:10 Pt 2 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Cholinesterase Inhibitors; Clozapine; Dementia; Diagnosis, Differential; Disease Progression; Dopamine Agents; Humans; Iatrogenic Disease; Levodopa; Lewy Body Disease; Neuroprotective Agents; Nootropic Agents; Parkinson Disease; Parkinsonian Disorders; Phenylcarbamates; Psychotropic Drugs; Rivastigmine; Serotonin Antagonists	2007
[Dementia with Lewy bodies]. Der Nervenarzt, 2000, Volume: 71, Issue:12 Topics: Aged; Brain; Cholinesterase Inhibitors; Diagnosis, Differential; Diagnostic Imaging; Female; Humans; Levodopa; Lewy Body Disease; Male	2000
[Parkinson disease: diagnostic and therapeutic criteria]. Presse medicale (Paris, France : 1983), 2001, Mar-03, Volume: 30, Issue:8 Topics: Activities of Daily Living; Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Globus Pallidus; Humans; Indoles; Levodopa; Lewy Body Disease; Lisuride; Male; Mental Status Schedule; Neurosurgery; Parkinson Disease; Parkinsonian Disorders; Piribedil; Psychiatric Status Rating Scales; Serotonin Receptor Agonists; Stereotaxic Techniques; Supranuclear Palsy, Progressive; Surveys and Questionnaires; Thalamus	2001
Dementia with Lewy bodies: clinical features and treatment. Drugs & aging, 2001, Volume: 18, Issue:6 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Diagnosis, Differential; Humans; Levodopa; Lewy Body Disease; Middle Aged; Motor Activity	2001

Trials

9 trial(s) available for levodopa and Cortical Lewy Body Disease

Article	Year
Efficacy of Adjunctive Therapy with Zonisamide Versus Increased Dose of Levodopa for Motor Symptoms in Patients with Dementia with Lewy Bodies: The Randomized, Controlled, Non-Inferiority DUEL Study. Journal of Alzheimer's disease : JAD, 2023, Volume: 95, Issue:1 Topics: Humans; Levodopa; Lewy Body Disease; Zonisamide	2023
Adjunct zonisamide to levodopa for DLB parkinsonism: A randomized double-blind phase 2 study. Neurology, 2018, 02-20, Volume: 90, Issue:8 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Lewy Body Disease; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Zonisamide	2018
Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies. Movement disorders : official journal of the Movement Disorder Society, 2008, Nov-15, Volume: 23, Issue:15 Topics: Aged; Dopamine Agonists; Female; Follow-Up Studies; Hallucinations; Humans; Levodopa; Lewy Body Disease; Male; Mental Disorders; Movement Disorders	2008
Levodopa use and sleep in patients with dementia with Lewy bodies. Movement disorders : official journal of the Movement Disorder Society, 2009, Mar-15, Volume: 24, Issue:4 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Lewy Body Disease; Male; Mental Status Schedule; Parkinson Disease; Severity of Illness Index; Sleep Wake Disorders; Surveys and Questionnaires; Time Factors	2009
Levodopa response in dementia with lewy bodies: a 1-year follow-up study. Parkinsonism & related disorders, 2010, Volume: 16, Issue:8 Topics: Aged; Antiparkinson Agents; Female; Follow-Up Studies; Humans; Levodopa; Lewy Body Disease; Male; Parkinson Disease	2010
Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia. Dementia and geriatric cognitive disorders, 2011, Volume: 32, Issue:4 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Dementia; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Factor Analysis, Statistical; Female; Humans; Levodopa; Lewy Body Disease; Male; Memantine; Neuropsychological Tests; Parkinson Disease; Quality of Life; Treatment Outcome	2011
The role of levodopa in the management of dementia with Lewy bodies. Journal of neurology, neurosurgery, and psychiatry, 2005, Volume: 76, Issue:9 Topics: Administration, Oral; Age Factors; Aged; Antiparkinson Agents; Basal Ganglia Diseases; Female; Humans; Levodopa; Lewy Body Disease; Male; Mental Status Schedule; Severity of Illness Index; Treatment Outcome	2005
Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies. Journal of neurology, neurosurgery, and psychiatry, 2006, Volume: 77, Issue:12 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Attention; Cognition; Cognition Disorders; Female; Humans; Levodopa; Lewy Body Disease; Male; Motor Skills; Parkinson Disease; Treatment Outcome	2006
Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:6 Topics: Aged; Antipsychotic Agents; Dibenzothiazepines; Humans; Levodopa; Lewy Body Disease; Parkinson Disease; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Quetiapine Fumarate; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2002

Other Studies

29 other study(ies) available for levodopa and Cortical Lewy Body Disease

Article	Year
A case of Lewy body disease and anaplastic astrocytoma presenting with atypical parkinsonism. Neuropathology : official journal of the Japanese Society of Neuropathology, 2022, Volume: 42, Issue:6 Topics: Humans; Levodopa; Lewy Body Disease; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders	2022
Mitochondrial biogenesis, telomere length and cellular senescence in Parkinson's disease and Lewy body dementia. Scientific reports, 2022, 10-20, Volume: 12, Issue:1 Topics: Cellular Senescence; Dementia; DNA, Mitochondrial; Humans; Levodopa; Lewy Body Disease; Organelle Biogenesis; Parkinson Disease; Telomere	2022
Pharmacological management of dementia with Lewy bodies with a focus on zonisamide for treating parkinsonism. Expert opinion on pharmacotherapy, 2021, Volume: 22, Issue:3 Topics: Brain; Europe; Humans; Levodopa; Lewy Body Disease; Zonisamide	2021
Zonisamide for DLB parkinsonism: An old drug used in a new context. Neurology, 2018, 02-20, Volume: 90, Issue:8 Topics: Double-Blind Method; Humans; Levodopa; Lewy Body Disease; Parkinsonian Disorders; Zonisamide	2018
Fact-finding survey on diagnostic procedures and therapeutic interventions for parkinsonism accompanying dementia with Lewy bodies. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2019, Volume: 19, Issue:4 Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Lewy Body Disease; Middle Aged; Muscle Rigidity; Neurologists; Parkinsonian Disorders; Physicians; Postural Balance; Psychiatry; Psychotropic Drugs; Tremor	2019
[The use of clozapine and levodopa for the treatment of persistent visual hallucinations and parkinsonism in Lewy body dementia]. Tijdschrift voor psychiatrie, 2013, Volume: 55, Issue:4 Topics: Aged; Antipsychotic Agents; Brain; Clozapine; Comorbidity; Hallucinations; Humans; Levodopa; Lewy Body Disease; Male; Parkinson Disease; Treatment Outcome	2013
Levodopa treatment and mood fluctuation in dementia with Lewy bodies: a case report. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2013, Volume: 13, Issue:4 Topics: Affect; Aged; Comorbidity; Dopamine Agents; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Levodopa; Lewy Body Disease; Mood Disorders; Treatment Outcome	2013
Utility of 123I-FP-CIT SPECT for dementia diagnoses and therapeutic strategies in elderly patients. The journal of nutrition, health & aging, 2014, Volume: 18, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dopamine Plasma Membrane Transport Proteins; Female; Geriatric Assessment; Hallucinations; Humans; Levodopa; Lewy Body Disease; Male; Retrospective Studies; Tomography, Emission-Computed, Single-Photon	2014
Serotonin syndrome following levodopa treatment in diffuse Lewy body disease. BMJ case reports, 2014, Sep-22, Volume: 2014 Topics: Diagnosis, Differential; Humans; Levodopa; Lewy Body Disease; Male; Middle Aged; Serotonin Syndrome	2014
Dementia with Lewy bodies presenting marked tongue protrusion and bite due to lingual dystonia: A case report. Rinsho shinkeigaku = Clinical neurology, 2016, 06-22, Volume: 56, Issue:6 Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Bites and Stings; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Indoles; Laryngeal Diseases; Levodopa; Lewy Body Disease; Middle Aged; Olanzapine; Receptors, Dopamine D1; Tetrahydronaphthalenes; Thiophenes; Tongue Diseases	2016
Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia. Dementia and geriatric cognitive disorders, 2008, Volume: 26, Issue:4 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aged; Aged, 80 and over; Antidepressive Agents; Antiparkinson Agents; Autopsy; Cerebral Cortex; Dementia; Depression; Female; Humans; Levodopa; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Receptor, Serotonin, 5-HT1A; Serotonin Receptor Agonists; Temporal Lobe	2008
Activities of daily living, cerebral glucose metabolism, and cognitive reserve in Lewy body and Parkinson's disease. Dementia and geriatric cognitive disorders, 2008, Volume: 26, Issue:5 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Brain Chemistry; Cognition; Data Interpretation, Statistical; Dementia; Education; Female; Functional Laterality; Glucose; Humans; Image Processing, Computer-Assisted; Levodopa; Lewy Body Disease; Male; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography	2008
Adjunct treatment with levodopa in a patient with dementia with Lewy bodies, delusions and severe neuroleptic hypersensitivity syndrome: some comments. International psychogeriatrics, 2010, Volume: 22, Issue:4 Topics: Antiparkinson Agents; Clozapine; Delusions; Drug Therapy, Combination; Humans; Levodopa; Lewy Body Disease; Movement Disorders; Neuroleptic Malignant Syndrome; Severity of Illness Index	2010
Adjunct treatment with levodopa in a patient with dementia with Lewy bodies, delusions and severe neuroleptic hypersensitivity syndrome. International psychogeriatrics, 2010, Volume: 22, Issue:4 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Clozapine; Delusions; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Levodopa; Lewy Body Disease; Neuroleptic Malignant Syndrome; Quetiapine Fumarate; Severity of Illness Index	2010
Dysphagia due to isoniazid therapy for tuberculosis in a patient with Lewy body dementia. Auris, nasus, larynx, 2013, Volume: 40, Issue:3 Topics: Aged; Antitubercular Agents; Deglutition Disorders; Dopamine Agents; Drug Interactions; Endoscopy; Female; Fluoroscopy; Humans; Isoniazid; Levodopa; Lewy Body Disease; Tuberculosis, Pleural; Video Recording	2013
Brain amyloid and cognition in Lewy body diseases. Movement disorders : official journal of the Movement Disorder Society, 2012, Volume: 27, Issue:8 Topics: Aged; Amyloid beta-Peptides; Aniline Compounds; Antiparkinson Agents; Apolipoprotein E3; Cognition; Cognitive Dysfunction; Female; Genotype; Humans; Levodopa; Lewy Body Disease; Male; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Thiazoles	2012
Personalized medicine strategies for managing patients with parkinsonism and cognitive deficits. Metabolism: clinical and experimental, 2013, Volume: 62 Suppl 1 Topics: alpha-Synuclein; Alzheimer Disease; Antiparkinson Agents; Biomarkers; Cognition; Cognition Disorders; Diagnosis, Differential; Diagnostic Imaging; Frontotemporal Dementia; Genetic Markers; Genetic Testing; Glucosylceramidase; Humans; Huntington Disease; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Levodopa; Lewy Body Disease; Mutation; Parkinson Disease; Precision Medicine; Protein Serine-Threonine Kinases	2013
Cohort study of prevalence and phenomenology of tremor in dementia with Lewy bodies. Journal of neurology, 2013, Volume: 260, Issue:7 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Comorbidity; Double-Blind Method; Female; Humans; Levodopa; Lewy Body Disease; Male; Middle Aged; Prevalence; Severity of Illness Index; Treatment Outcome; Tremor	2013
[Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine]. Nederlands tijdschrift voor geneeskunde, 2003, Jan-04, Volume: 147, Issue:1 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Carbamates; Cholinesterase Inhibitors; Drug Therapy, Combination; Humans; Levodopa; Lewy Body Disease; Male; Neuroprotective Agents; Olanzapine; Phenylcarbamates; Pirenzepine; Risperidone; Rivastigmine; Treatment Outcome	2003
Essential tremor course and disability: A clinicopathologic study of 20 cases. Neurology, 2004, Mar-23, Volume: 62, Issue:6 Topics: Adrenergic beta-Antagonists; Age of Onset; Aged; Antiparkinson Agents; Disability Evaluation; Disease Progression; Essential Tremor; Female; Humans; Levodopa; Lewy Body Disease; Male; Propranolol; Saskatchewan; Supranuclear Palsy, Progressive	2004
Apraxia of lid opening: dose-dependent response to carbidopa-levodopa. Pharmacotherapy, 2004, Volume: 24, Issue:3 Topics: Aged; Apraxia, Ideomotor; Blepharospasm; Carbidopa; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Eyelid Diseases; Eyelids; Female; Humans; Levodopa; Lewy Body Disease; Time Factors	2004
L-dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia. Neurology, 2004, Jul-27, Volume: 63, Issue:2 Topics: Aged; Aged, 80 and over; Dementia; Dopamine Agonists; Female; Humans; Levodopa; Lewy Body Disease; Male; Parkinson Disease; Predictive Value of Tests; Prospective Studies	2004
Longitudinal study of cerebral blood flow SPECT in Parkinson's disease with dementia, and dementia with Lewy bodies. International journal of geriatric psychiatry, 2005, Volume: 20, Issue:8 Topics: Aged; Antiparkinson Agents; Cerebrovascular Circulation; Cholinesterase Inhibitors; Dementia; Female; Humans; Image Processing, Computer-Assisted; Levodopa; Lewy Body Disease; Longitudinal Studies; Male; Motor Activity; Parkinson Disease; Psychological Tests; Tomography, Emission-Computed, Single-Photon	2005
The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats. British journal of pharmacology, 2005, Volume: 146, Issue:4 Topics: Animals; Basal Ganglia; Behavior, Animal; Carbamates; Cholinesterase Inhibitors; Dopamine; Hippocampus; Hyperkinesis; Indans; Levodopa; Lewy Body Disease; Male; Monoamine Oxidase Inhibitors; Motor Activity; Muscarinic Antagonists; Norepinephrine; Phenylcarbamates; Rats; Rats, Sprague-Dawley; Rivastigmine; Scopolamine; Serotonin; Time Factors; Tranylcypromine; Tryptophan	2005
[Dementia with Lewy Bodies and its differentiation from Alzheimer's disease]. Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 2007, Volume: 21, Issue:2 Topics: Alzheimer Disease; Antiparkinson Agents; Antipsychotic Agents; Austria; Brain; Cholinesterase Inhibitors; Diagnosis, Differential; Humans; Levodopa; Lewy Body Disease; Neuropsychological Tests	2007
Low myocardial MIBG uptake in multiple system atrophy with incidental Lewy body pathology: an autopsy case report. Movement disorders : official journal of the Movement Disorder Society, 2008, May-15, Volume: 23, Issue:7 Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Fatal Outcome; Humans; Levodopa; Lewy Body Disease; Male; Multiple System Atrophy; Myocardium; Radiopharmaceuticals	2008
[Parkinson's disease]. Presse medicale (Paris, France : 1983), 2001, Mar-03, Volume: 30, Issue:8 Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Catechols; Depressive Disorder; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Follow-Up Studies; Humans; Indoles; Levodopa; Lewy Body Disease; Neuroprotective Agents; Nitriles; Parkinson Disease; Parkinsonian Disorders; Pergolide; Psychiatric Status Rating Scales; Psychotic Disorders; Time Factors	2001
Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Archives of neurology, 2002, Volume: 59, Issue:1 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Brain; Disease Progression; Female; Humans; Incidence; Levodopa; Lewy Bodies; Lewy Body Disease; Male; Middle Aged; Neurofibrillary Tangles; Parkinson Disease; Plaque, Amyloid; Prevalence; Retrospective Studies	2002
Improvement of both psychotic symptoms and Parkinsonism in a case of dementia with Lewy bodies by the combination therapy of risperidone and L-DOPA. Progress in neuro-psychopharmacology & biological psychiatry, 2002, Volume: 26, Issue:1 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Brain; Drug Therapy, Combination; Female; Humans; Levodopa; Lewy Body Disease; Magnetic Resonance Imaging; Risperidone	2002